A carregar...
Acute profound thrombocytopenia after abciximab therapy during coronary angioplasty
Since the extensive use of abciximab, a potent antiplatelet agent directed against GP IIb/IIIa platelet receptors, to prevent ischemic complications of percutaneous transluminal coronary angioplasty, few cases of thrombocytopenia have been observed. This paper reports a case of acute profound thromb...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655764/ https://ncbi.nlm.nih.gov/pubmed/9825202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960211115 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|